Stefano Malvolti is a vaccinology expert and entrepreneur with over 25 years of experience in vaccine policy and implementation, epidemiology, strategy, and forecasting in the public and private sectors. He co-founded MMGH Consulting in 2017 with the vision of providing highly qualified and independent advice to public and non-profit clients to design, implement, and evaluate programs and products targeting vaccine-preventable and neglected diseases. He is a Member of the Board of Fondazione Achille Sclavo, an NGO that facilitates vaccine development for neglected diseases. Before MMGH, Stefano served as CEO at Univac, an early-stage vaccine biotech company, was the Director of Vaccine Implementation at Gavi, the Vaccine Alliance, and held positions in public policy, the supply chain, strategy, and finance at Novartis, PATH, and Baxter Healthcare. Stefano holds a Master of Public Health degree from Johns Hopkins Bloomberg School of Public Health and a Master of Business Economics degree from Bocconi University. He has published several papers on access to vaccines and on vaccine development and implementation.